Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Hyperfiltration in ubiquitin C-terminal hydrolase L1-deleted mice.

Boisvert NC, Holterman CE, Thibodeau JF, Nasrallah R, Kamto E, Comin CH, Costa LDF, Carter A, Hébert RL, Gutsol A, Cron GO, Lacoste B, Gray DA, Kennedy CR.

Clin Sci (Lond). 2018 Jul 18;132(13):1453-1470. doi: 10.1042/CS20180085. Print 2018 Jul 18.

PMID:
29739827
2.

Podocyte-derived microparticles promote proximal tubule fibrotic signaling via p38 MAPK and CD36.

Munkonda MN, Akbari S, Landry C, Sun S, Xiao F, Turner M, Holterman CE, Nasrallah R, Hébert RL, Kennedy CRJ, Burger D.

J Extracell Vesicles. 2018 Feb 2;7(1):1432206. doi: 10.1080/20013078.2018.1432206. eCollection 2018.

3.

PGE2 EP1 receptor inhibits vasopressin-dependent water reabsorption and sodium transport in mouse collecting duct.

Nasrallah R, Zimpelmann J, Eckert D, Ghossein J, Geddes S, Beique JC, Thibodeau JF, Kennedy CRJ, Burns KD, Hébert RL.

Lab Invest. 2018 Mar;98(3):360-370. doi: 10.1038/labinvest.2017.133. Epub 2017 Dec 18.

PMID:
29251736
4.

Effect of red dyes on blue light phototoxicity against VSC producing bacteria in an experimental oral biofilm.

Jeffet U, Nasrallah R, Sterer N.

J Breath Res. 2016 Nov 21;10(4):046011.

PMID:
27869109
5.

Identification of novel regulators of developmental hematopoiesis using Endoglin regulatory elements as molecular probes.

Nasrallah R, Fast EM, Solaimani P, Knezevic K, Eliades A, Patel R, Thambyrajah R, Unnikrishnan A, Thoms J, Beck D, Vink CS, Smith A, Wong J, Shepherd M, Kent D, Roychoudhuri R, Paul F, Klippert J, Hammes A, Willnow T, Göttgens B, Dzierzak E, Zon LI, Lacaud G, Kouskoff V, Pimanda JE.

Blood. 2016 Oct 13;128(15):1928-1939. Epub 2016 Aug 23. Erratum in: Blood. 2017 Nov 16;130(20):2234.

6.

PDGF-AB and 5-Azacytidine induce conversion of somatic cells into tissue-regenerative multipotent stem cells.

Chandrakanthan V, Yeola A, Kwan JC, Oliver RA, Qiao Q, Kang YC, Zarzour P, Beck D, Boelen L, Unnikrishnan A, Villanueva JE, Nunez AC, Knezevic K, Palu C, Nasrallah R, Carnell M, Macmillan A, Whan R, Yu Y, Hardy P, Grey ST, Gladbach A, Delerue F, Ittner L, Mobbs R, Walkley CR, Purton LE, Ward RL, Wong JW, Hesson LB, Walsh W, Pimanda JE.

Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):E2306-15. doi: 10.1073/pnas.1518244113. Epub 2016 Apr 4.

7.

PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes.

Hassouneh R, Nasrallah R, Zimpelmann J, Gutsol A, Eckert D, Ghossein J, Burns KD, Hébert RL.

Diabetologia. 2016 Jun;59(6):1318-28. doi: 10.1007/s00125-016-3916-5. Epub 2016 Mar 19.

PMID:
26995650
8.

PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.

Nasrallah R, Hassouneh R, Hébert RL.

J Am Soc Nephrol. 2016 Mar;27(3):666-76. doi: 10.1681/ASN.2015050528. Epub 2015 Aug 28. Review.

9.

Prostaglandin E2 increases proximal tubule fluid reabsorption, and modulates cultured proximal tubule cell responses via EP1 and EP4 receptors.

Nasrallah R, Hassouneh R, Zimpelmann J, Karam AJ, Thibodeau JF, Burger D, Burns KD, Kennedy CR, Hébert RL.

Lab Invest. 2015 Sep;95(9):1044-55. doi: 10.1038/labinvest.2015.79. Epub 2015 Jun 29.

10.

Endoglin potentiates nitric oxide synthesis to enhance definitive hematopoiesis.

Nasrallah R, Knezevic K, Thai T, Thomas SR, Göttgens B, Lacaud G, Kouskoff V, Pimanda JE.

Biol Open. 2015 May 15;4(7):819-29. doi: 10.1242/bio.011494.

11.

Chronic kidney disease: targeting prostaglandin E2 receptors.

Nasrallah R, Hassouneh R, Hébert RL.

Am J Physiol Renal Physiol. 2014 Aug 1;307(3):F243-50. doi: 10.1152/ajprenal.00224.2014. Epub 2014 Jun 25. Review.

12.

PTGER1 deletion attenuates renal injury in diabetic mouse models.

Thibodeau JF, Nasrallah R, Carter A, He Y, Touyz R, Hébert RL, Kennedy CRJ.

Am J Pathol. 2013 Dec;183(6):1789-1802. doi: 10.1016/j.ajpath.2013.08.022. Epub 2013 Oct 8.

PMID:
24113456
13.

NADPH oxidases, reactive oxygen species, and the kidney: friend and foe.

Sedeek M, Nasrallah R, Touyz RM, Hébert RL.

J Am Soc Nephrol. 2013 Oct;24(10):1512-8. doi: 10.1681/ASN.2012111112. Epub 2013 Aug 22. Review.

14.

Cyclooxygenase-2 mediates induction of the renal stanniocalcin-1 gene by arginine vasopressin.

Law AY, Hébert RL, Nasrallah R, Langenbach R, Wong CK, Wagner GF.

Mol Cell Endocrinol. 2013 Dec 5;381(1-2):210-9. doi: 10.1016/j.mce.2013.07.008. Epub 2013 Jul 20.

PMID:
23877023
15.

Celecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental.

Nasrallah R, Robertson SJ, Karsh J, Hébert RL.

Clin Sci (Lond). 2013 Jun;124(11):685-94. doi: 10.1042/CS20120543.

PMID:
23305077
16.

Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus.

Cherney DZ, Reich HN, Jiang S, Har R, Nasrallah R, Hébert RL, Lai V, Scholey JW, Sochett EB.

Am J Physiol Regul Integr Comp Physiol. 2012 Oct 1;303(7):R710-8. doi: 10.1152/ajpregu.00286.2012. Epub 2012 Aug 1.

17.

Troglitazone induces extracellular matrix and cytoskeleton remodeling in mouse collecting duct cells.

Corinaldi J, Nasrallah R, Clark J, Paris G, Miura P, Jasmin BJ, Hébert RL.

J Biomed Biotechnol. 2012;2012:507057. doi: 10.1155/2012/507057. Epub 2012 Mar 5.

18.

Hypertonicity increases sodium transporters in cortical collecting duct cells independently of PGE2.

Nasrallah R, Paris G, Hébert RL.

Biochem Biophys Res Commun. 2012 Feb 10;418(2):372-7. doi: 10.1016/j.bbrc.2012.01.028. Epub 2012 Jan 12.

PMID:
22266310
19.

An efficient approach to isolation and characterization of pre- and postnatal umbilical cord lining stem cells for clinical applications.

Gonzalez R, Griparic L, Umana M, Burgee K, Vargas V, Nasrallah R, Silva F, Patel A.

Cell Transplant. 2010;19(11):1439-49. doi: 10.3727/096368910X514260. Epub 2010 Jun 29.

PMID:
20587136
20.

Renal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1 diabetes.

Cherney DZ, Miller JA, Scholey JW, Nasrallah R, Hébert RL, Dekker MG, Slorach C, Sochett EB, Bradley TJ.

Diabetes Care. 2010 Jun;33(6):1344-6. doi: 10.2337/dc09-2340. Epub 2010 Mar 23.

21.

Thiazolidinediones alter growth and epithelial cell integrity, independent of PPAR-γ and MAPK activation, in mouse M1 cortical collecting duct cells.

Nasrallah R, Clark J, Corinaldi J, Paris G, Miura P, Jasmin BJ, Hébert RL.

Am J Physiol Renal Physiol. 2010 May;298(5):F1105-12. doi: 10.1152/ajprenal.00735.2009. Epub 2010 Feb 17.

22.

Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2(Akita) mice.

Nasrallah R, Robertson SJ, Hébert RL.

Am J Nephrol. 2009;30(4):346-53. doi: 10.1159/000229304. Epub 2009 Jul 17.

PMID:
19609076
23.

The PPARδ ligand GW501516 reduces growth but not apoptosis in mouse inner medullary collecting duct cells.

Clark J, Nasrallah R, Hébert RL.

PPAR Res. 2009;2009:706283. doi: 10.1155/2009/706283. Epub 2009 Mar 4.

24.

Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus.

Cherney DZ, Scholey JW, Nasrallah R, Dekker MG, Slorach C, Bradley TJ, Hébert RL, Sochett EB, Miller JA.

Am J Physiol Renal Physiol. 2008 Jun;294(6):F1336-41. doi: 10.1152/ajprenal.00574.2007. Epub 2008 Apr 9.

25.

The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes.

Cherney DZ, Miller JA, Scholey JW, Bradley TJ, Slorach C, Curtis JR, Dekker MG, Nasrallah R, Hébert RL, Sochett EB.

Diabetes. 2008 Mar;57(3):688-95. Epub 2007 Dec 14.

26.

Prostaglandins in the kidney: developments since Y2K.

Nasrallah R, Clark J, Hébert RL.

Clin Sci (Lond). 2007 Oct;113(7):297-311. Review.

PMID:
17760567
27.

Renal prostaglandin E2 receptor (EP) expression profile is altered in streptozotocin and B6-Ins2Akita type I diabetic mice.

Nasrallah R, Xiong H, Hébert RL.

Am J Physiol Renal Physiol. 2007 Jan;292(1):F278-84. Epub 2006 Sep 5.

28.

Why do neighbors have different environmental priorities? Analysis of environmental risk perception in a Beirut neighborhood.

El-Zein A, Nasrallah R, Nuwayhid I, Kai L, Makhoul J.

Risk Anal. 2006 Apr;26(2):423-35.

PMID:
16573631
29.

Determinants of the willingness-to-participate in an environmental intervention in a beirut neighborhood.

El-Zein A, Nasrallah R, Nuwayhid I.

Environ Manage. 2006 Feb;37(2):200-8.

PMID:
16328676
30.

Prostacyclin signaling in the kidney: implications for health and disease.

Nasrallah R, Hébert RL.

Am J Physiol Renal Physiol. 2005 Aug;289(2):F235-46. Review.

31.

Reduced IP receptors in STZ-induced diabetic rat kidneys and high-glucose-treated mesangial cells.

Nasrallah R, Hébert RL.

Am J Physiol Renal Physiol. 2004 Oct;287(4):F673-81. Epub 2004 May 25.

32.

Characterization of the PGI2/IP system in cultured rat mesangial cells.

Nasrallah R, Landry A, Scholey JW, Hébert RL.

Prostaglandins Leukot Essent Fatty Acids. 2004 May;70(5):455-64.

PMID:
15062848
33.

Increased expression of cyclooxygenase-1 and -2 in the diabetic rat renal medulla.

Nasrallah R, Landry A, Singh S, Sklepowicz M, Hébert RL.

Am J Physiol Renal Physiol. 2003 Dec;285(6):F1068-77. Epub 2003 Jul 29.

34.

Localization of IP in rabbit kidney and functional role of the PGI(2)/IP system in cortical collecting duct.

Nasrallah R, Nusing RM, Hébert RL.

Am J Physiol Renal Physiol. 2002 Oct;283(4):F689-98.

35.

Effect of COX-2 inhibitor NS-398 on expression of PGE2 receptor subtypes in M-1 mouse CCD cells.

Nasrallah R, Laneuville O, Ferguson S, Hébert RL.

Am J Physiol Renal Physiol. 2001 Jul;281(1):F123-32.

36.

Molecular and biochemical characterization of prostacyclin receptors in rat kidney.

Nasrallah R, Zimpelmann J, Singh S, Hébert RL.

Am J Physiol Renal Physiol. 2001 Feb;280(2):F266-77.

37.

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.

Henderson DC, Cagliero E, Gray C, Nasrallah RA, Hayden DL, Schoenfeld DA, Goff DC.

Am J Psychiatry. 2000 Jun;157(6):975-81.

PMID:
10831479
38.

Bradykinin inhibits ceramide production and activates phospholipase D in rabbit cortical collecting duct cells.

Liu G, Kleine L, Nasrallah R, Hébert RL.

Am J Physiol. 1999 Apr;276(4 Pt 2):F589-98.

PMID:
10198419
39.

Supplemental Content

Loading ...
Support Center